For example, the t(8;21) AML group displayed large variability in the expression of CD34, HLA-DR, and CD13, whereas, for MLL AML blasts, the most important differences were observed for CD34, CD117, HLA-DR, CD13, CD11b, CD64, CD36, CD105, CD71, and CD33, in addition to the FSC and SSC parameters (Supplementary Figure 5). This evidence concerns the gene FCGR1A and acute myeloid leukemia.